Lazard Asset Management’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,349
Closed -$296K 2248
2023
Q2
$296K Buy
+6,349
New +$296K ﹤0.01% 1239